GxMed Nordic ApS: Financial statements 2022
CVR: 37089842
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
GxMed Nordic ApS (CVR 37089842) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024. The solvency ratio was 46.6%.
- Gross Profit
- DKK -144,834
- Profit/Loss
- DKK -117,961
- Equity
- DKK 1,488,024
- Total Assets
- DKK 3,193,944
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -145K | -118K | 1.5M | - |
| 2021 | - | 572K | 1.1M | 1.6M | 3 |
| 2020 | - | 4.6M | 2.3M | 550K | 3 |
| 2018 | - | 2.6M | -442K | 421K | 2 |
| 2017 | - | -506K | -1.1M | 863K | - |
Official annual report
Keep an eye on GxMed Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout GxMed Nordic ApS
GxMed Nordic ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GxMed Nordic IVS. The company is owned by HHR HOLDING A/S. The company has 1 employee (2020). In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024.
